Works matching IS 11732563 AND DT 2022 AND VI 42 AND IP 10

Results: 8

Healthcare Utilization of Patients with Opioid Use Disorder in US Hospitals from 2016 to 2019: Focusing on Racial and Regional Variances.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 10, p. 853, doi. 10.1007/s40261-022-01192-0

By:

Kim, Sun Jung;
Medina, Mar;
Chang, Jongwha

Publication type:

Article

Evaluation of the Effect of Uridine Diphosphate-Glucuronosyltransferases (UGT) Inhibition by Valproic Acid on Vixotrigine Pharmacokinetics in Healthy Volunteers.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 10, p. 829, doi. 10.1007/s40261-022-01194-y

By:

Zhao, Yuan;
Kotecha, Mona;
Finnigan, Helen;
Serenko, Michael;
Naik, Himanshu

Publication type:

Article

Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 10, p. 865, doi. 10.1007/s40261-022-01193-z

By:

Surjan, Juliana;
Grossi, Julia Diniz;
Del Porto, José Alberto;
Delfino, Rodrigo Simonini;
de Oliveira Cerqueira, Raphael;
Lucchese, Ana Cecília;
Magalhães, Eduardo;
Del Sant, Lorena Catarina;
Tuena, Marco Aurélio;
Nakahira, Carolina;
Fava, Victor Augusto Rodovalho;
Steglich, Matheus Souza;
Abdo, Guilherme Lozi;
Barbosa, Matheus Ghossain;
Sarin, Luciana Maria;
Lacerda, Acioly Luiz Tavares

Publication type:

Article

Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 10, p. 813, doi. 10.1007/s40261-022-01191-1

By:

Abdel-Qader, Derar H.;
Abdel-Qader, Hasan;
Silverthorne, Jennifer;
Kongkaew, Chuenjid;
Al Meslamani, Ahmad Z.;
Hayajneh, Wail;
Ata, Osama M. Abu;
Shnaigat, Walid;
AbuRuz, Salah;
Al Nsour, Mohannad;
Alhariri, Abdallah;
Shnewer, Khaldoun;
Da'ssan, Mohammad;
Obeidat, Nathir M.;
Nusair, Khaldoon E.;
Jalamdeh, Mothafer S.;
Hawari, Feras;
Khader, Khaldoun;
Hakim, Tareq;
Hammad, Fatima A.

Publication type:

Article

Reporting of COVID-19 Reinfection and Potential Role of Immunosuppressant/Immunomodulating Agents: A Cross-Sectional Observational Analysis Based on a Spontaneous Reporting Database.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 10, p. 807, doi. 10.1007/s40261-022-01200-3

By:

Beyzarov, Elena;
Chen, Yan;
Caubel, Patrick

Publication type:

Article

Protective Duration of ChAdOx1 and BNT162b2 Vaccines Against SARS-CoV-2 Infection.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 10, p. 799, doi. 10.1007/s40261-022-01195-x

By:

Alfaleh, Amjad;
Alkattan, Abdullah;
Alzaher, Abrar;
Radwan, Nashwa;
Mahmoud, Nagla;
Alageel, Alaa;
Alhabib, Dina;
Alsalameen, Eman;
Sagor, Khlood;
Haji, Alhan;
Alfaifi, Amal;
Alabdulkareem, Khaled;
Ibrahim, Mona

Publication type:

Article

AVT02: An Adalimumab Biosimilar.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 10, p. 875, doi. 10.1007/s40261-022-01196-w

By:

Kang, Connie

Publication type:

Article

Cost-Utility Analysis of CYP2C19 Genotype Detection for Selection of Acid-Suppressive Therapy with Lansoprazole or Vonoprazan for Patients with Reflux Esophagitis in China.

Published in:

Clinical Drug Investigation, 2022, v. 42, n. 10, p. 839, doi. 10.1007/s40261-022-01188-w

By:

Zhang, Zhuolin;
Bao, Yuwen;
Cai, Lele;
Gu, Yajie;
Yang, Ting;
Li, Xin

Publication type:

Article